Orexigen Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

OREX 4.12 +0.06 (1.48%)
price chart
Orexigen Therapeutics Has Substantial Upside For Bull Investors (OREX)
Assuming OREX catches only 1/100 of this market for a year-long prescription of Contrave on the company's "Direct Save" program (i.
Related articles »  
Orexigen Therapeutics Analyst Coverage Initiated with Price Target by ...
Orexigen Therapeutics, Inc. (NASDAQ: OREX) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity.
Stocks Buzz - Orexigen Therapeutics, Inc. (NASDAQ:OREX), SandRidge Energy ...  Techsonian (press release)
Related articles »  
Stocks to Watch - Orexigen Therapeutics, Inc. (NASDAQ:OREX), Lennox ...
Orexigen Therapeutics, Inc. (NASDAQ:OREX) and its its wholly-owned subsidiary Takeda Pharmaceuticals have launched sales of Contrave extended-release tablets for chronic weight management in adults.
Related articles »  
Health Care Stocks In Focus: Orexigen Therapeutics, Inc.(NASDAQ:OREX ...
Takeda Pharmaceutical Company, its entirely owned subsidiary Takeda Pharmaceuticals U.S.A and Orexigen Therapeutics, Inc. (NASDAQ:OREX) jointly declared that Contrave extensive launch tablets are now accessible to patients by instruction in drug ...
Related articles »  
Orexigen On A Tear - In The Wrong Direction
Based on the review of the data and the company's response to the CHMP lists of questions, at the time of the withdrawal the CHMP had some concerns and was of the provisional opinion that Belviq could not have been approved for weight control in obese ...
Are People Too Concerned About Orexigen's Contrave Label? (OREX)
With its FDA Approval on September 11th 2014, Orexigen's (NASDAQ:OREX) Contrave became only the third anti-obesity drug to be approved by the FDA in over 10 years.
Takeda, Orexigen Therapeutics (OREX) Announces Availability of CONTRAVE  StreetInsider.com (subscription)
Movers to Watch - Steven Madden, Ltd. (NASDAQ:SHOO), Orexigen ...  Techsonian (press release)
Related articles »  
Top Stock Watch: iGATE Corporation (NASDAQ:IGTE), Orexigen Therapeutics ...
iGATE Corporation (NASDAQ:IGTE) reported Q3 financial results on Wednesday, with earnings in-line with the consensus of analysts polled by Capital IQ and revenues slightly beating the consensus.
What To Watch For As Orexigen's Launch Approaches  Seeking Alpha (registration)
Active Movers - Knowles Corp (NYSE:KN), Orexigen Therapeutics, Inc ...  Techsonian (press release)
Related articles »  
Investor's Alert �Orexigen Therapeutics, Inc. (NASDAQ:OREX), Avis Budget ...
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen Therapeutics, Inc. (OREX) jointly released that Contrave� (naltrexone HCI and bupropion HCI) extended-release tablets are now available to patients by prescription in pharmacies across the United States.
Top News: Orexigen Therapeutics (NASDAQ:OREX), Netlist (NASDAQ:NLST ...  Gaining Green
Related articles »  
Stock Buzz: Xilinx , Infinera Corp, Achillion Pharma , Orexigen Therapeutics ...
Xilinx, Inc. (NASDAQ:XLNX) : Announced its collaboration with China Mobile Research Institute for the development of virtualized 5G wireless networks in a special signing ceremony during the 5G Forum at the International Mobile Internet Conference.
Stocks Trending Alert � Orexigen Therapeutics, Inc. (NASDAQ:OREX), Sanchez ...
Orexigen Therapeutics, Inc. (OREX) a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity.
Related articles »